Physician

Carrie A Mihordin, D.O.

According to 2025 Medicare claims, Carrie Mihordin, D.O. (NPI: 1548458672) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is MID-AMERICA RHEUMATOLOGY CONSULTANTS (NPI: 1043204852; TIN: 480929053) and primary practice location at 66209-3749.

Mihordin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 239 traditional Medicare patients, billed 162,285 HCPCS/CPT codes, and received $1,389,397 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 538 prescription claims across 131 beneficiaries totaling $116,820 in drug costs, led by Methotrexate (Methotrexate Sodium). Open Payments data shows 13 records totaling $278. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,148,383 to $1,389,397. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	98,494	$1,148,383
2016	493	155,414	$1,651,558
2017	538	165,673	$2,337,787
2018	618	309,949	$4,380,281
2019	520	318,901	$3,888,132
2020	475	313,162	$3,446,596
2021	340	258,377	$2,594,469
2022	303	157,733	$1,375,456
2023	261	172,858	$1,557,014
2024	239	162,285	$1,389,397

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	1,075	$159,248
2016	186	1,322	$174,289
2017	233	1,585	$154,830
2018	320	2,401	$233,347
2019	311	2,349	$258,162
2020	284	2,048	$262,369
2021	202	1,092	$200,588
2022	164	801	$185,065
2023	151	625	$90,521
2024	131	538	$116,820

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	196	362	$99
96413	Administration of chemotherapy into vein, 1 hour or less	131	430	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	77	96	$72
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	60	392	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	58	72	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Methotrexate	Methotrexate Sodium	108	8,849	$2,740
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	68	4,280	$2,497
Leflunomide	Leflunomide	21	1,410	$1,340
Sulfasalazine Dr	Sulfasalazine	29	1,502	$1,170
Celecoxib	Celecoxib	21	1,230	$699

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$278	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carrie A. Mihordin, D.O.?

Tedicare shows public-source Medicare data for Carrie A. Mihordin, D.O. (NPI 1548458672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carrie A. Mihordin, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carrie A. Mihordin, D.O.?

Carrie A. Mihordin, D.O. is linked to MID-AMERICA RHEUMATOLOGY CONSULTANTS (billing NPI 1043204852) in the available physician profile data.

Does Carrie A. Mihordin, D.O. have Open Payments data?

Carrie A. Mihordin, D.O. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.